Praxis Precision Medicine Q2 2024 GAAP EPS $(1.74) Beats $(2.31) Estimate, Sales $357.000K Miss $870.000K Estimate
Author: Benzinga Newsdesk | August 13, 2024 07:14am
Praxis Precision Medicine (NASDAQ:
PRAX) reported quarterly losses of $(1.74) per share which beat the analyst consensus estimate of $(2.31) by 24.68 percent. The company reported quarterly sales of $357.000 thousand which missed the analyst consensus estimate of $870.000 thousand by 58.97 percent. This is a 54.29 percent decrease over sales of $781.000 thousand the same period last year.
Posted In: PRAX